Intuitive Surgical, Inc. (NASDAQ:ISRG)

CAPS Rating: 4 out of 5

Intuitive Surgical makes and maintains the da Vinci robotic device, an advanced surgical system that lets surgeons perform minimally invasive surgery.

Results 1 - 20 of 703 : 1 2 3 4 5 6 7 8 9 10 Next »

Recs

0
Member Avatar FrankoJames (93.70) Submitted: 12/12/2014 8:32:26 AM : Outperform Start Price: $509.00 ISRG Score: +3.46

This company has a great product installed in leading hospitals all around the world. I have a 600 dollar price target on this equity with or without my parental support. Please note that sales of adult diapers should correlate with the amount of procedures that are undertaken by the ISRG systems worldwide. So far, thank you for the innovation from Intuitive Surgical and the outstanding doctors worldwide. Please note that 3D Systems has an outstanding program available to help surgical to learn robotic techniques.

Recs

0
Member Avatar nrynn (< 20) Submitted: 8/4/2014 11:04:11 AM : Underperform Start Price: $450.93 ISRG Score: -10.61

I feel the field is still immature short term. Would recommend a buy at dips with a 5+ year hold.

Recs

0
Member Avatar racoveanul (80.75) Submitted: 7/3/2014 1:46:51 PM : Outperform Start Price: $404.04 ISRG Score: +27.46

I expect at least a point a week from this stock, for the next five years.

Recs

0
Member Avatar Estrogen (48.68) Submitted: 5/21/2014 11:57:48 PM : Outperform Start Price: $365.27 ISRG Score: +36.47

buy on the dip. technology has to rule in the long run in this industry.

Recs

0
Member Avatar 2gud2btrue (66.32) Submitted: 5/1/2014 10:21:19 AM : Underperform Start Price: $360.84 ISRG Score: -37.60

Target $275

Recs

2
Member Avatar SlothropsMonkey (89.53) Submitted: 4/1/2014 12:54:19 PM : Outperform Start Price: $298.01 ISRG Score: +28.26

Intuitive Surgical makes fancy surgery gizmos that help surgeons to do their job more precisely and with less body invasiveness for the patient which consequently allows for quicker recovery times. After the stock-ticker ISRG has gone sideways and down and sideways some more for a while, today there was good news that the FDA approved their newest fancy surgery gizmo––that to Monkey's eye looks like a good-guy white spider––and fixes many of the previous model's shortcomings. But don't take my word for it: check out this video below and remember that adding to your winners is the way to go for long-term investing success. Did the stock just pop a bit? Sure. But imagine how many more percentage points it has to go if you believe in the quality and mission of the company which just got unequivocally better.

http://www.engadget.com/2014/04/01/da-vinci-xi-surgical-robot/

Recs

0
Member Avatar papacdk (< 20) Submitted: 3/26/2014 8:54:58 PM : Outperform Start Price: $422.48 ISRG Score: +14.14

Precision surgical machine when used by a skilled surgeon. Skilled equates to approximately 500 plus surgeries. Too many doctors ,not enough SURGERIES under their beIt's . It,s a training issue. and not the robot. I had the surgery, prostate removal, in a small Texas town by a surgeon with over 800 surgeries. All went well. Less blood loss, better vision through magnification. Left the next day.

Recs

0
Member Avatar NathanExplosion (77.25) Submitted: 3/21/2014 12:40:59 PM : Underperform Start Price: $435.50 ISRG Score: -12.06

Monopolized hospitals for 15 years. Same product for 15 years. Competitors large (Stryker/Covidien) and small (Titan Medical) will introduce products in the coming years that will make the Da Vinci system obsolete. There isn't a steep enough discount for me to buy ISRG.

Recs

0
Member Avatar rofgile (99.41) Submitted: 1/26/2014 12:46:25 PM : Outperform Start Price: $411.20 ISRG Score: +14.03

Medical technology, has benefits and a good moat. Downside if devices have technical issues.

Recs

1
Member Avatar TMFTypeoh (82.50) Submitted: 1/10/2014 4:36:11 PM : Outperform Start Price: $412.07 ISRG Score: +16.68

One of my favorite companies. Period.

Recs

0
Member Avatar NuclearSteve (72.70) Submitted: 1/10/2014 2:42:17 PM : Outperform Start Price: $422.20 ISRG Score: +13.51

It is time for this stock to turn around. Chart shows it.

Recs

0
Member Avatar GVFool15 (71.93) Submitted: 1/7/2014 2:23:13 PM : Outperform Start Price: $382.75 ISRG Score: +16.73

Robotic surgery is becoming the standard and Intuitive Surgical is the standard in the industry. As health innovations expand, so will ISRG and for that reason it should outperform the market over the next half decade.

Recs

1
Member Avatar JoesCash (81.42) Submitted: 9/26/2013 11:15:48 AM : Outperform Start Price: $369.15 ISRG Score: +22.05

Because it cuts like a knife... and it feels so right.

Recs

0
Member Avatar Googlespooch (20.11) Submitted: 9/22/2013 11:05:17 PM : Outperform Start Price: $373.31 ISRG Score: +21.36

I have a feeling that robot surgery is here to stay. This stock has seen a ridiculous amount of punishment over the last few months considering the potential of robot-administered surgeries and operations. ISRG posted an 18% growth in Da Vinci operations. Does that not mean something to investors? That is a big jump and is the kind of signal that should alert investors to further opportunity.

Recs

0
Member Avatar jontynought (< 20) Submitted: 8/18/2013 2:16:50 AM : Outperform Start Price: $379.33 ISRG Score: +15.56

Growing market

Recs

0
Member Avatar TerryHoodSr (65.20) Submitted: 8/6/2013 10:37:52 PM : Outperform Start Price: $374.96 ISRG Score: +19.96

growth potential

Recs

0
Member Avatar TMFBwithbike (57.47) Submitted: 7/29/2013 9:00:38 PM : Outperform Start Price: $391.46 ISRG Score: +13.76

How can you pass this up at this price? ISRG has many options to grow their business, first mover and rule breaker.

Recs

0
Member Avatar TMFFlygal (99.30) Submitted: 7/22/2013 1:34:16 PM : Outperform Start Price: $544.01 ISRG Score: -49.94

Ouch this one hurts not just because today my caps score is so awful, but I own this one in real life and I am down there too. But I am hanging in and considering adding to this holding. I think that many people will benefit from the advances in surgery available via robots. I will keep an eye on procedure numbers, but I think this one is a long term winner.

Recs

0
Member Avatar mfoolid (78.48) Submitted: 7/22/2013 12:01:45 PM : Outperform Start Price: $399.66 ISRG Score: +11.28

drop in price recently has been overdone

Recs

1
Member Avatar VincentChua (53.72) Submitted: 7/20/2013 10:50:08 PM : Outperform Start Price: $393.33 ISRG Score: +13.34

Despite current litigation issues, docs are still using the Da Vinci system, customers are still loving it & figures still makes sense (at least for now). Below is an except from marketwatch article.

"Second quarter of 2013 instruments and accessories revenue increased 18% to $265 million from $224 million in the second quarter of 2012. The growth in instruments and accessories revenue is the result of growth in da Vinci surgical procedures and increased utilization of new products. da Vinci surgical procedures grew approximately 18% in the second quarter of 2013 compared to the second quarter of 2012, driven primarily by growth in general surgery, U.S. gynecology and international urology procedures, partially offset by a decline in U.S. prostatectomy procedures."

So I'm still bullish on their growth story & I'm strong feeling it'll beat the market & this dip may just prove to be a great buying opportunity in the long run.

Featured Broker Partners


Advertisement